Real-World Effectiveness of Eptinezumab after Treatment with Subcutaneous CGRP Monoclonal Antibodies in Patients with Migraine

被引：0
|
作者：
Casaletto, Emily [1 ]
Yang, Qiu Zi [1 ]
Waters, John [1 ]
Curran, John [1 ]
Lowe, Austin [1 ]
Yuan, Hsiangkuo [1 ]
机构：
[1] Thomas Jefferson Univ, Dept Neurol, Philadelphia, PA USA
来源：
NEUROLOGY | 2023年 / 100卷 / 17期
关键词：
D O I：
10.1212/WNL.0000000000203712
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P12-12.009
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Real-world evidence of the effectiveness and satisfaction with eptinezumab treatment in patients with chronic migraine
    Argoff, C.
    Khan, F.
    Herzog, S.
    Smith, R.
    Kotak, S.
    Sopina, L.
    Soni-Brahmbhatt, S.
    Kymes, S.
    HEADACHE, 2023, 63 : 160 - 161
  • [2] Potential Predictors of Response to CGRP Monoclonal Antibodies in Chronic Migraine: Real-World Data
    Sanchez-Rodriguez, Carmen
    Gago-Veiga, Ana Beatriz
    Garcia-Azorin, David
    Guerrero-Peral, Angel Luis
    Gonzalez-Martinez, Alicia
    CURRENT PAIN AND HEADACHE REPORTS, 2024, 28 (12) : 1265 - 1272
  • [3] Effectiveness and tolerability of eptinezumab in treating patients with migraine resistant to conventional preventive medications and CGRP (receptor) antibodies: a multicentre retrospective real-world analysis from Germany
    Scheffler, Armin
    Wenzel, Pauline
    Bendig, Merle
    Gendolla, Astrid
    Basten, Jale
    Kleinschnitz, Christoph
    Nsaka, Michael
    Lindner, Diana
    Naegel, Steffen
    Burow, Philipp
    Fleischmann, Robert
    Holle, Dagny
    JOURNAL OF HEADACHE AND PAIN, 2024, 25 (01):
  • [4] The impact of anti-CGRP monoclonal antibodies in resistant migraine patients: a real-world evidence observational study
    Torres-Ferrus, Marta
    Gallardo, Victor J.
    Alpuente, Alicia
    Caronna, Edoardo
    Gine-Cipres, Eulalia
    Pozo-Rosich, Patricia
    JOURNAL OF NEUROLOGY, 2021, 268 (10) : 3789 - 3798
  • [5] The impact of anti-CGRP monoclonal antibodies in resistant migraine patients: a real-world evidence observational study
    Marta Torres-Ferrús
    Victor J. Gallardo
    Alicia Alpuente
    Edoardo Caronna
    Eulalia Gine-Cipres
    Patricia Pozo-Rosich
    Journal of Neurology, 2021, 268 : 3789 - 3798
  • [6] Eptinezumab Anti-CGRP monoclonal antibody Treatment of migraine
    Lu, Lingyun
    Liu, Meijun
    Hu, Songshan
    Liu, Yao
    Yang, Dongdong
    Hong, Peiwei
    DRUGS OF THE FUTURE, 2017, 42 (10) : 609 - 615
  • [7] Effectiveness and tolerability of monoclonal antibodies targeting CGRP pathway for migraine prevention: Real-world data from the Migraine Registry (ReMig) in the Czech Republic
    Nezadal, T.
    Dolezal, T.
    Pejrilova, D.
    Turkova, B.
    Markova, J.
    Bartkova, A.
    Klecka, L.
    JOURNAL OF HEADACHE AND PAIN, 2024, 25
  • [8] Anti-CGRP monoclonal antibodies in resistant migraine: preliminary real-world effectiveness and clinical predictors of response at two years
    Pons-Fuster, E.
    Lozano-Caballero, O.
    Martin-Balbuena, S.
    Lucas-Rodenas, C.
    Mancebo-Gonzalez, A.
    De Gorostiza-Frias, I.
    Gonzalez-Ponce, C. M.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2024, : 1317 - 1326
  • [9] Synergism of Anti-CGRP Monoclonal Antibodies and OnabotulinumtoxinA in the Treatment of Chronic Migraine: A Real-World Retrospective Chart Review
    Salim, Amira
    Hennessy, Elise
    Sonneborn, Claire
    Hogue, Olivia
    Biswas, Sudipa
    Mays, Maryann
    Suneja, Aarushi
    Ahmed, Zubair
    Mata, Ignacio F.
    CNS DRUGS, 2024, 38 (06) : 481 - 491
  • [10] Synergism of Anti-CGRP Monoclonal Antibodies and OnabotulinumtoxinA in the Treatment of Chronic Migraine: A Real-World Retrospective Chart Review
    Amira Salim
    Elise Hennessy
    Claire Sonneborn
    Olivia Hogue
    Sudipa Biswas
    MaryAnn Mays
    Aarushi Suneja
    Zubair Ahmed
    Ignacio F. Mata
    CNS Drugs, 2024, 38 : 481 - 491
12345